ID

35028

Description

Traditional Chinese Medicine as Preventive Method for Osteoporosis Induced by Adjuvant Endocrine Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT02455154

Lien

https://clinicaltrials.gov/show/NCT02455154

Mots-clés

Versions (1)
  1. 11/02/2019 11/02/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

11 février 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT02455154

Anglais

Eligibility Breast Cancer NCT02455154

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed invasive breast cancer;
Description

Invasive carcinoma of breast

Type de données

boolean

Alias
UMLS CUI [1]
C0853879
post-surgery, primary lesion been removed;
Description

Status post Operative Surgical Procedures | Primary Lesion Removed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0543467
UMLS CUI [2,1]
C1402294
UMLS CUI [2,2]
C0849355
post-menopausal patients or pre-menopausal patients who will receive ovarian function suppression;
Description

Postmenopausal state | Premenopausal state Impending Ovarian Function Tests

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2,1]
C0232969
UMLS CUI [2,2]
C0332190
UMLS CUI [2,3]
C0029930
histologically confirmed er and/or pr positive ;
Description

Estrogen receptor positive | Progesterone receptor positive

Type de données

boolean

Alias
UMLS CUI [1]
C0279754
UMLS CUI [2]
C0279759
receiving adjuvant ais therapy in the following one years;
Description

Aromatase Inhibitors Adjuvant therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0593802
UMLS CUI [1,2]
C0677850
leukocyte ≥ 3*10(9)/l; platelets ≥ 75*10(9)/l;
Description

White Blood Cell Count procedure | Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0032181
serum glutamate oxaloacetate(ast/sgot) or serum glutamic-pyruvic transaminase(alt/sgpt) <2.5 times of upper limit of normal range;
Description

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
serum creatinine/blood urea nitrogen(bun) ≤ upper limit of normal (unl) range;
Description

Creatinine measurement, serum | Blood urea nitrogen measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0005845
written informed consent according to the local ethics committee equirements;
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastatic breast cancer;
Description

Secondary malignant neoplasm of female breast

Type de données

boolean

Alias
UMLS CUI [1]
C0346993
received neo-adjuvant endocrine therapy;
Description

Hormone Therapy Neoadjuvant

Type de données

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C1298676
history of pelvic fracture or bone metabolic disease;
Description

Fracture of pelvis | Metabolic Bone Disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0149531
UMLS CUI [2]
C0005944
received drugs interfering bone metabolism in the last 12 months;
Description

Pharmaceutical Preparations Interfering Bone metabolism

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0596204
baseline bone mineral density: t < -2sd;
Description

Bone Mineral Density T score

Type de données

boolean

Alias
UMLS CUI [1,1]
C0177804
UMLS CUI [1,2]
C3854607
with other primary malignant disease;
Description

Primary tumor Other

Type de données

boolean

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C0205394
with severe non-malignant co-morbidity that will influence long-term follow up;
Description

Comorbidity Severe Influence Long-term Follow-up | Exception Malignant disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C4054723
UMLS CUI [1,4]
C1517942
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0442867
known severe hypersensitivity to any drugs in this study;
Description

Severe allergy Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1,1]
C2945656
UMLS CUI [1,2]
C0013230
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT02455154

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast
Item
histologically confirmed invasive breast cancer;
boolean
C0853879 (UMLS CUI [1])
Status post Operative Surgical Procedures | Primary Lesion Removed
Item
post-surgery, primary lesion been removed;
boolean
C0231290 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C1402294 (UMLS CUI [2,1])
C0849355 (UMLS CUI [2,2])
Postmenopausal state | Premenopausal state Impending Ovarian Function Tests
Item
post-menopausal patients or pre-menopausal patients who will receive ovarian function suppression;
boolean
C0232970 (UMLS CUI [1])
C0232969 (UMLS CUI [2,1])
C0332190 (UMLS CUI [2,2])
C0029930 (UMLS CUI [2,3])
Estrogen receptor positive | Progesterone receptor positive
Item
histologically confirmed er and/or pr positive ;
boolean
C0279754 (UMLS CUI [1])
C0279759 (UMLS CUI [2])
Aromatase Inhibitors Adjuvant therapy
Item
receiving adjuvant ais therapy in the following one years;
boolean
C0593802 (UMLS CUI [1,1])
C0677850 (UMLS CUI [1,2])
White Blood Cell Count procedure | Platelet Count measurement
Item
leukocyte ≥ 3*10(9)/l; platelets ≥ 75*10(9)/l;
boolean
C0023508 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
serum glutamate oxaloacetate(ast/sgot) or serum glutamic-pyruvic transaminase(alt/sgpt) <2.5 times of upper limit of normal range;
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Creatinine measurement, serum | Blood urea nitrogen measurement
Item
serum creatinine/blood urea nitrogen(bun) ≤ upper limit of normal (unl) range;
boolean
C0201976 (UMLS CUI [1])
C0005845 (UMLS CUI [2])
Informed Consent
Item
written informed consent according to the local ethics committee equirements;
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Secondary malignant neoplasm of female breast
Item
metastatic breast cancer;
boolean
C0346993 (UMLS CUI [1])
Hormone Therapy Neoadjuvant
Item
received neo-adjuvant endocrine therapy;
boolean
C0279025 (UMLS CUI [1,1])
C1298676 (UMLS CUI [1,2])
Fracture of pelvis | Metabolic Bone Disorder
Item
history of pelvic fracture or bone metabolic disease;
boolean
C0149531 (UMLS CUI [1])
C0005944 (UMLS CUI [2])
Pharmaceutical Preparations Interfering Bone metabolism
Item
received drugs interfering bone metabolism in the last 12 months;
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0596204 (UMLS CUI [1,3])
Bone Mineral Density T score
Item
baseline bone mineral density: t < -2sd;
boolean
C0177804 (UMLS CUI [1,1])
C3854607 (UMLS CUI [1,2])
Primary tumor Other
Item
with other primary malignant disease;
boolean
C0677930 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Comorbidity Severe Influence Long-term Follow-up | Exception Malignant disease
Item
with severe non-malignant co-morbidity that will influence long-term follow up;
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C4054723 (UMLS CUI [1,3])
C1517942 (UMLS CUI [1,4])
C1705847 (UMLS CUI [2,1])
C0442867 (UMLS CUI [2,2])
Severe allergy Investigational New Drugs
Item
known severe hypersensitivity to any drugs in this study;
boolean
C2945656 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial